Skip to main content
Premium Trial:

Request an Annual Quote

Cynvenio, St. Luke's Partner on Breast Cancer Study

NEW YORK (GenomeWeb) – Cynvenio Biosystems today announced the launch of a breast cancer monitoring study in partnership with Saint Luke's Cancer Institute.

The goal of the study — which is directed at patients at high risk of relapse after neoadjuvant chemotherapy — is to evaluate the use of liquid biopsy and natural killer cell testing for the early detection of recurrent breast cancer. In the first phase, patients who are scheduled for neoadjuvant chemotherapy before surgery will get tested. In the next phase, patients will be tested after surgery.

Cynvenio offers the ClearID Breast Cancer test, which sequences 27 genes commonly mutated in breast cancer. The test analyzes cell-free DNA and circulating tumor cells before and after treatment, while assessing the correlation of natural killer cell activity to a patient's response to chemotherapy. The firm said that the study is anticipated to determine whether the surveillance of CTC and NK cells are predictive of clinical relapse following neoadjuvant therapy. 

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.